| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 305 |
| 1 | ADALIMUMAB | 233 |
| 2 | METHOTREXATE SODIUM | 196 |
| 3 | ETONOGESTREL AND ETHINYL ESTRADIOL | 178 |
| 4 | INFLIXIMAB | 175 |
| 5 | METHOTREXATE | 173 |
| 6 | COPPER | 130 |
| 7 | FINGOLIMOD HCL | 105 |
| 8 | ETANERCEPT | 84 |
| 9 | FOLIC ACID | 77 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL | 1 | 0.0278 |
| 1 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| 2 | KETOCONAZOLE 1% | 1 | 0.0082 |
| 3 | ETONOGESTREL AND ETHINYL ESTRADIOL | 178 | 0.0080 |
| 4 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 5 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 19 | 0.0069 |
| 7 | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | 1 | 0.0055 |
| 8 | EUCALYPTOL, MENTHOL, UNSPECIFIED FORM, METHYL SALICYLATE, AND THYMOL | 1 | 0.0045 |
| 9 | NATALIZUMAB-SZTN | 1 | 0.0042 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 501 |
| 1 | Progestin-containing Intrauterine System [EPC] | 306 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 295 |
| 3 | Estrogen [EPC] | 231 |
| 4 | Corticosteroid [EPC] | 205 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 172 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 156 |
| 7 | Copper-containing Intrauterine Device [EPC] | 131 |
| 8 | Integrin Receptor Antagonist [EPC] | 112 |
| 9 | Vitamin C [EPC] | 99 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 131 | 0.0026 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 4 | 0.0019 |
| 2 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 3 | Provitamin D2 Compound [EPC] | 55 | 0.0018 |
| 4 | Progestin [EPC] | 501 | 0.0017 |
| 5 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 7 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 19 | 0.0014 |
| 8 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |